Innovative Sterilization TSO3 develops unique low-temperature sterilization technology for heat-sensitive medical devices, positioning it as a leading provider in the high-growth sterilization equipment market targeted at hospitals and healthcare facilities.

Strategic Partnerships The company's collaborations with prominent institutions like Mount Sinai showcase its active engagement with major healthcare systems, providing opportunities to expand product deployment and increase market penetration across hospitals and clinics.

Acquisition Opportunity Having been acquired by Stryker for over $50 million, TSO3 presents potential for sales initiatives aligned with Stryker's extensive distribution channels and existing customer base within the medical device sterilization sector.

Growing Market Presence With minimal revenue currently between $1M and $10M, TSO3 offers growth potential for sales efforts aimed at expanding adoption of its proprietary sterilization solutions among medical device manufacturers and healthcare providers.

Technological Differentiation TSO3's advanced sterilization process provides a competitive edge that appeals to hospitals seeking reliable, high-tech solutions for heat-sensitive devices, creating opportunities to position its products as essential in modern sterilization workflows.